Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCRTR2 | O43614 | 18/20 | 0.56 |
| ▸ | HCRTR1 | O43613 | 17/20 | 0.56 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14844190 | 0.89 | HCRTR1 (0.59) | HCRTR2HCRTR1MAPTNPC1RAB9A | |
| SCHEMBL14844247 | 0.81 | HCRTR1 (0.63) | HCRTR2HCRTR1MAPTNPC1RAB9A | |
| SCHEMBL14844321 | 0.81 | HCRTR1 (0.83) | HCRTR2HCRTR1MAPTNPC1RAB9A | |
| SCHEMBL14843972 | 0.81 | HCRTR2 (0.63) | HCRTR2HCRTR1NPC1RAB9A | |
| SCHEMBL14844019 | 0.81 | HCRTR2 (0.68) | HCRTR2HCRTR1 | |
| SCHEMBL14843833 | 0.81 | HCRTR2 (0.68) | HCRTR2HCRTR1 | |
| SCHEMBL14843969 | 0.81 | HCRTR2 (0.61) | HCRTR2HCRTR1MAPTNPC1RAB9A | |
| SCHEMBL14844188 | 0.80 | HCRTR2 (0.63) | HCRTR2HCRTR1NPC1RAB9A | |
| SCHEMBL14844259 | 0.79 | HCRTR2 (0.57) | HCRTR2HCRTR1NPC1RAB9A | |
| SCHEMBL14843823 | 0.78 | HCRTR2 (0.59) | HCRTR2HCRTR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2013050938-A1 | 3,7-DIAZABICYCLO[3.3.1]NONANE AND 9-OXA-3,7-DIAZABICYCLO[3.3.1]NONANE DERIVATIVES | ACTELION PHARMACEUTICALS LTD (CH) | 2013-04-11 | — | — | WO | disclosed |